Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of autoimmune diseases on risk and survival in female cancers.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Long-term benefits of induction therapy in NMO: a case report.
Human Umbilical Cord Stem Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Immunoinflammation and Remyelination.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Fluctuations of MS births and UV-light exposure.
c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
FDA Approves New Drug to Treat Psoriasis
Progressive multiple sclerosis: pathology and pathogenesis.
Childhood transverse myelitis and its mimics.
Modulators of Microglia: a Patent Review.
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
From genes to characteristics of multiple sclerosis.
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.

Pages